tradingkey.logo

Cidara Therapeutics Inc <CDTX.OQ> expected to post a loss of $3.54 a share - Earnings Preview

ReutersMay 6, 2025 8:15 PM
  • Cidara Therapeutics Inc CDTX.OQ CDTX.O is expected to show a fall in quarterly revenue when it reports results on May 8 for the period ending March 31 2025

  • ​LSEG's mean analyst estimate for Cidara Therapeutics Inc is for a loss of $3.54 per share.

  • The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 7 "strong buy" or "buy," no "hold" and no "sell" or "strong sell."

  • The mean earnings estimate of analysts was unchanged in the last three months. ​

  • Wall Street's median 12-month price target for Cidara Therapeutics Inc is $35.00​, above​ its last closing price of $21.50. ​​​

Previous quarterly performance (using preferred earnings measure in US dollars). ​

QUARTER ENDING

STARMINESMARTESTIMATE®

LSEG IBES ESTIMATE

ACTUAL

BEAT, MET, MISSED

SURPRISE %

Dec. 31 2024

-3.52

-3.62

-5.37

Missed

-48.3

Sep. 30 2024

-3.55

-4.25

-2.45

Beat

42.4

Jun. 30 2024

-4.01

-3.22

-1.39

Beat

56.9​

Mar. 31 2024

-0.20

-0.20

-2.28

Missed

-1,040

​​Dec. 31 2023

-2.07

-0.80

Beat

61.3

Sep. 30 2023

-3.19

-3.25

-1.80

Beat

44.6​

Jun. 30 2023

-2.04

-2.60

-2.80

Missed

-7.7

Mar. 31 2023

-0.41

-0.73

0.60

Beat

181.8

This summary was machine generated May 6 at 20:15 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI